Maddalena Mereu, PhD - Publications

Affiliations: 
Intramural Research Program National Institute on Drug Abuse 
Area:
Molecular Targets and Medication Discovery Branch

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/j.ymthe.2019.08.005  0.36
2019 Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/j.bbi.2019.06.006  0.36
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 3560. PMID 30158661 DOI: 10.1038/s41467-018-06062-y  0.48
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 2265. PMID 29891954 DOI: 10.1038/s41467-018-04711-w  0.48
2018 Cavaccini A, Gritti M, Giorgi A, Locarno A, Heck N, Migliarini S, Bertero A, Mereu M, Margiani G, Trusel M, Catelani T, Marotta R, De Luca MA, Caboche J, Gozzi A, et al. Serotonergic Signaling Controls Input-Specific Synaptic Plasticity at Striatal Circuits. Neuron. PMID 29706583 DOI: 10.1016/j.neuron.2018.04.008  0.32
2017 Giorgi A, Migliarini S, Galbusera A, Maddaloni G, Mereu M, Margiani G, Gritti M, Landi S, Trovato F, Bertozzi SM, Armirotti A, Ratto GM, De Luca MA, Tonini R, Gozzi A, et al. Brain-wide Mapping of Endogenous Serotonergic Transmission via Chemogenetic fMRI. Cell Reports. 21: 910-918. PMID 29069598 DOI: 10.1016/j.celrep.2017.09.087  0.32
2017 Ciampoli M, Contarini G, Mereu M, Papaleo F. Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task. Scientific Reports. 7: 9936. PMID 28855580 DOI: 10.1038/s41598-017-10112-8  0.36
2017 Pintori N, Loi B, Mereu M. Synthetic cannabinoids: the hidden side of Spice drugs. Behavioural Pharmacology. PMID 28692429 DOI: 10.1097/FBP.0000000000000323  0.36
2017 Huang H, Guadagna S, Mereu M, Ciampoli M, Pruzzo G, Ballard T, Papaleo F. A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity. Psychopharmacology. PMID 28378204 DOI: 10.1007/s00213-017-4611-z  0.36
2016 Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, et al. Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening. Pharmacology, Biochemistry, and Behavior. PMID 27569602 DOI: 10.1016/j.pbb.2016.08.007  0.56
2016 Managò F, Mereu M, Mastwal S, Mastrogiacomo R, Scheggia D, Emanuele M, De Luca MA, Weinberger DR, Wang KH, Papaleo F. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell Reports. PMID 27524619 DOI: 10.1016/j.celrep.2016.07.044  0.48
2016 Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience. 10: 153. PMID 27147945 DOI: 10.3389/fnins.2016.00153  0.32
2015 Varcasia A, Brianti E, Tamponi C, Pipia AP, Cabras PA, Mereu M, Dantas-Torres F, Scala A, Otranto D. Simultaneous infection by four feline lungworm species and implications for the diagnosis. Parasitology Research. 114: 317-21. PMID 25367212 DOI: 10.1007/s00436-014-4207-z  0.56
2015 Mereu M, Tronci V, Chun LE, Thomas AM, Green JL, Katz JL, Tanda G. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Addiction Biology. 20: 91-103. PMID 23910902 DOI: 10.1111/adb.12080  0.56
2014 Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G. Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine. Biological Psychiatry. 76: 802-9. PMID 24853388 DOI: 10.1016/j.biopsych.2014.03.031  0.56
2013 Mereu M, Bonci A, Newman AH, Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology. 229: 415-34. PMID 23934211 DOI: 10.1007/s00213-013-3232-4  0.56
2013 Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology. 229: 307-21. PMID 23612854 DOI: 10.1007/s00213-013-3109-6  0.56
2013 Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL. Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 605-15. PMID 23187725 DOI: 10.1038/npp.2012.224  0.56
2013 Enrico P, Sirca D, Mereu M, Peana AT, Mercante B, Diana M. Acute restraint stress prevents nicotine-induced mesolimbic dopaminergic activation via a corticosterone-mediated mechanism: a microdialysis study in the rat. Drug and Alcohol Dependence. 127: 8-14. PMID 22809896 DOI: 10.1016/j.drugalcdep.2012.06.006  0.56
2012 Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biological Psychiatry. 72: 405-13. PMID 22537794 DOI: 10.1016/j.biopsych.2012.03.022  0.56
2011 Sirca D, Enrico P, Mereu M, Peana AT, Diana M. L-cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcoholism, Clinical and Experimental Research. 35: 862-9. PMID 21303385 DOI: 10.1111/j.1530-0277.2010.01416.x  0.56
2011 Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, Katz JL, Tanda G. Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological Psychiatry. 69: 208-17. PMID 20950794 DOI: 10.1016/j.biopsych.2010.07.026  0.56
2010 Peana AT, Muggironi G, Calvisi G, Enrico P, Mereu M, Nieddu M, Boatto G, Diana M. l-Cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats. Pharmacology, Biochemistry, and Behavior. 94: 431-7. PMID 19879891 DOI: 10.1016/j.pbb.2009.10.005  0.56
2009 Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M. Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug and Alcohol Dependence. 100: 265-71. PMID 19070441 DOI: 10.1016/j.drugalcdep.2008.10.010  0.56
2007 Enrico P, Sirca D, Mereu M. Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy. Progress in Brain Research. 166: 323-30. PMID 17956795 DOI: 10.1016/S0079-6123(07)66029-4  0.56
Show low-probability matches.